Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P2B001 in Early Parkinson's Disease
NCT01968460Phase 3Completed
- Sponsor
- Pharma Two B
- Start
- Dec 2013
- Primary completion
- May 2015
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 2
01
Overview
A Phase 3 trial of pramipexole, rasagiline in Parkinson's disease (PD), sponsored by Pharma Two B. Started Dec 2013; status: completed.
02
Drugs
pramipexolerasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01968460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968460.